source · text/csv
source_34ee48f0e1144366
sha256 0ad1c6ccf3459c91af6d594b6b4ba86c8d6e8b8739a3806bb9611dad86046840
by researka:v2 · 2026-06-08 09:43:48.703669+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Semaglutide for the treatment of overweight and obesity: A review,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "3d1248c8-7873-4a08-876e-3faa7b2b381a",
"researka_submission_id": "c2e46038-d454-4f3d-8c05-8809efa3b647",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/3d1248c8-7873-4a08-876e-3faa7b2b381a/sidecars/evidence_table.csv"
}